申请人:Phenomenome Discoveries Inc.
公开号:EP3231789A1
公开(公告)日:2017-10-18
The present invention describes methods for the diagnosis and differential diagnosis of the different forms of multiple sclerosis. The methods measure the intensities of specific small molecules called metabolites in samples from patients with clinically diagnosed relapsing-remitting or primary-progressive forms of multiple sclerosis and compare these intensities to the intensities observed in a population of healthy individuals, thus identifying markers of multiple sclerosis. A method is also provided for the differential diagnosis of subjects afflicted with relapsing-remitting multiple sclerosis from secondary-progressive multiple sclerosis.
本发明描述了诊断和鉴别诊断不同形式多发性硬化症的方法。这些方法测量临床诊断为复发-缓解型或原发性进展型多发性硬化症患者样本中被称为代谢物的特定小分子的强度,并将这些强度与在健康人群中观察到的强度进行比较,从而确定多发性硬化症的标记物。此外,还提供了一种方法,用于鉴别诊断复发缓解型多发性硬化症患者和继发性进展型多发性硬化症患者。